Back

Dynamic variation of renal function and novel or old HF biomarkers (ST2, Galectin 3, NT-proBNP) and response to cardiac resynchronization therapy (CRT)

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Devices / CRT/ ICD / Surgery Cardiac resynchronisation therapy HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Matteo Beltrami

Careggi, Florence (Italy)

29 More presentations in this session

Presentation thumbnail
Influence of chronic kidney disease on CRT response and clinical outcomes
Doctor M. Trepa (Porto, PT)
Abstract
Presentation thumbnail
Diastolic function, filling pressures in combination with B-type natriuretic pepetide levels affect cardiac resynchronization therapy response in chronic heart failure patients.
Assistant Professor E. Hatzinikolaou-Kotsakou (Thessaloniki, GR)
Presentation thumbnail
Role of global myocardial work in the identification of responders to CRT
Professor E. Donal (Rennes, FR)
Abstract
Presentation thumbnail
Level of testosterone as a predictor of response to cardiac resynchronisation therapy
Professor V. Kuznetsov (Tyumen, RU)
Abstract Slides
Presentation thumbnail
Multi-biomarkers laboratory strategy for outcome prediction in patients with severe systolic dysfunction submitted to CRT
Doctor M. Beltrami (Florence, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Devices / CRT/ ICD / Surgery

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources